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The Golgi complex consists of a series of stacked cistemae in most eukaryotes. Morphological
studies indicate the existence of intercisternal cross-bridge structures that may mediate
stacking, but their identity is unknown. We have identified a 400-kDa protein, giantin,
that is localized to the Golgi complex because its staining in double immunofluorescence
experiments was coincident with that of galactosyltransferase, both in untreated cells and
in cells treated with agents that disrupt Golgi structure. A monoclonal antibody against
giantin yielded Golgi staining in one avian and all mammalian cell types tested, indicating
that giantin is a conserved protein. Giantin exhibited reduced mobility on nonreducing
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, was recovered in membrane
fractions after differential centrifugation or sucrose flotation, and was not released from
membranes by carbonate extraction. Thus, giantin appears to be an integral component of
the Golgi membrane with a disulfide-linked lumenal domain. Strikingly, the majority of
the polypeptide chain is cytoplasmically disposed, because large (up to 350 kDa) proteolytic
fragments of giantin could be released from intact Golgi vesicles. This feature, a large
contiguous cytoplasmic domain, is present in the calcium-release channel of muscle that
cross-bridges the sarcoplasmic reticulum and transverse tubule membranes. Therefore,
giantin's localization, conservation, and physical properties suggest that it may participate
in forming the intercisternal cross-bridges of the Golgi complex.
INTRODUCTION
The Golgi apparatus participates in the glycosylation
and transport of proteins and lipids in the secretory
pathway (Mellman and Simons, 1992). Although our
knowledge of the proteins carrying out these functions
is far from complete, a substantial number of glycos-
ylation enzymes and components involved in vesicular
transport have been characterized (Rothman and Orci,
1992; Shaper and Shaper, 1992). Lagging considerably
behind is the identification of another class of proteins,
those that determine the structure and spatial organi-
zation of the Golgi complex itself.
A striking and highly conserved feature of the Golgi
apparatus is its cistemal organization. Stacks of flattened
Golgi membrane saccules can be identified in almost all
eukaryotic cells (Morre et al., 1971; Farquhar and Palade,
1981). Although regions of a cisterna can be highly fe-
nestrated (Rambourg and Clermont, 1990), the inter-
and intracistemal membrane distances, usually <15 nm
(Mollenhauer and Morre, 1991), appear to be relatively
constant over the surface area of the saccules. The cis-
ternal morphology is somehow maintained despite tre-
mendous membrane flow through the Golgi complex.
It is known that the cisternae are polarized with respect
to this flow and also with respect to the location of the
carbohydrate trimming and transferase enzymes that
reside in the Golgi complex (Dunphy and Rothman,
1985; Kornfeld and Komfeld, 1985; Rothman and Orci,
1992). Thus, the Golgi consists of a series of subcom-
partments, although the polarity in enzyme distribution
appears to reflect different mixtures in each cisterna
rather than cisterna-specific localization for each en-
zyme (Nilsson et al., 1993). It is likely that the stacking
of cistemae plays a role in establishing and maintaining
this polarity. In addition, stacking probably serves to
increase intra-Golgi transport efficiency by minimizing
the distance between successive subcompartments. The
flattened shape of Golgi saccules may increase glycos-
ylation efficiency by reducing the lumenal volume
(Mellman and Simons, 1992). Flattening may also pro-
mote vesicle and tubule formation, thereby facilitating
transport.
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Because of the near ubiquity of Golgi stacks in eu-
karyotes, it is likely that both stacking and flattening
involve highly conserved mechanisms. Little is known
about either process. Protease treatment of isolated
Golgi complexes leads to unstacking but not necessarily
rounding of cistemae, suggesting that flattening involves
the interaction of lumenal components, whereas stack-
ing depends on cytoplasmically disposed components
(Cluett and Brown, 1992). It has been hypothesized that
the electron densities that can be visualized between
cisternae in electron micrographs of plant and inver-
tebrate cells (Mollenhauer, 1965; Turner and Whaley,
1965) or animal cells (Franke et al., 1971; Cluett and
Brown, 1992) represent proteinaceous filaments or
bridges holding the Golgi cisternae together. Indeed,
these structures are no longer apparent on cisternae after
protease treatments that result in unstacking (Morre et
al., 1973; Cluett and Brown, 1992). Obviously, it will
be of great importance to identify the components that
give rise to this structure and to characterize their role
in the cisternal organization of the Golgi.
Additional aspects of Golgi structure are its spatial
disposition and continuity (degree of fragmentation),
which can vary extensively between different cell types
and during different stages of the cell cycle. Certain
organisms (e.g., higher plants, fungi, and invertebrates)
exhibit a number of discrete stacks (Mollenhauer and
Morre, 1991), whereas in many animal cells the Golgi
has a "ribbon-like" appearance because of the fact that
the flattened cisternae, which form a mass of loops and
turns readily visualized by light microscopy (see Figure
1), are actually part of one long continuous membrane
network (Rambourg and Clermont, 1990). During in-
terphase this structure is localized in a juxtanuclear re-
gion in close proximity to the microtubule organizing
center (Kreis, 1990). At mitosis the Golgi fragments and
redistributes to the cell periphery, and at telophase it
reforms at the cell center (Zeligs and Wollman, 1979;
Lucocq et al., 1987, 1989). It is likely that interactions
between the Golgi and microtubules are important in
this reorganization, because the microtubule network is
depolymerized at mitosis, and agents that induce dis-
ruption of the microtubule network cause Golgi dis-
persal (Kreis, 1990). Cytoplasmic dynein, a microtubule
minus-end-directed motor protein, has been implicated
in the postmitotic localization of the Golgi to the cen-
trosome, where the minus ends of microtubules are lo-
cated (Ho et al., 1989; Corthesy-Theulaz et al., 1992).
It therefore seems likely that there is a Golgi protein
with a cytoplasmic domain that mediates the linkage
of the organelle to motor components. In addition, there
may exist a more direct linkage of Golgi membranes to
microtubules because the in vitro interaction of Golgi
membranes and microtubules can take place in the ab-
sence of cytoplasmic dynein (Karecla and Kreis, 1992;
Murata et al., 1992).
Consideration of the structural aspects of the Golgi
apparatus thus indicates that unidentified proteins must
exist whose function is the establishment and regulation
of Golgi structure. Features of such proteins are likely
to include specific Golgi localization, conservation in
evolution, expression in all tissue types, membrane as-
sociation, relatively large domain facing the cytoplasm
(in contrast to the glycosylation enzymes, which have
short cytoplasmic tails [Paulson and Colley, 1989]), and
the ability to interact with cytoskeletal components.
Here we describe our initial experiments with an anti-
body that recognizes a novel Golgi protein, giantin, that
has many of these features. In particular the finding
that giantin has a cytoplasmic domain of .350 kDa
suggests that it is likely to be part of the structure that
cross-bridges the cisternae of the Golgi complex.
MATERIALS AND METHODS
Materials
Protease inhibitors (used at the following final concentrations: 1 jg/
ml pepstatin, lug/ml leupeptin, 1,ug/ml antipain, and 0.2 mM phe-
nylmethylsulfonyl fluoride) were from Sigma (St. Louis, MO). Pro-
teinase K and Triton X-100 were from Serva (Heidelberg, Germany).
Trypsin was from Worthington (Freehold, NJ). Antibodies used in-
cluded: a polyclonal antiserum against galactosyltransferase (Oscar,
gift of E. Berger, University of Zurich) and a purified monoclonal
antibody (mAb) against tubulin (1A2, gift of T. Kreis, University of
Geneva). In addition the following mAb hybridoma supernatants
(~- 10-fold concentrated by ammonium sulphate precipitation) were
used: G1/133 (anti-giantin), G1/221 (anti-human transferrin receptor)
(Sander and Hauri, unpublished data), G1/93 (anti-ERGIC 53)
(Schweizer et al., 1988), G1/296 (anti-p63) (Schweizer et al., 1993a),
GT2/36/118 (anti-galactosyltransferase) (Berger et al., 1986), and A1/
118 (anti-118a) (Linstedt, Schweizer and Hauri, unpublished data).
35S-methionine was isolated from Escherichia coli grown in the presence
of 35S-sulfate under sulfur-limited conditions.
Preparation of Anti-Golgi mAbs
The mouse mAb G1/133 was generated in a fusion described pre-
viously (Schweizer et al., 1988). Briefly, Golgi membranes were isolated
from Caco-2 cells (Stieger et al., 1988), mixed with Freund's adjuvant
(DIFCO Labs, Detroit, MI), and injected into mice. After fusion of
spleen and PAl myeloma cells, the culture supematants were screened
for reactivity to the Golgi membranes by dot blot (Hawkes et al.,
1982). The cultures positive by dot blot were expanded and tested
for reactivity in Caco-2 cells by immunofluorescence. G1/133 was
positive in both tests and therefore was subcloned by limiting dilution
and found to be of the IgGl subtype.
Immunofluorescence
All experiments were carried out on eight chamber glass slides (Miles
Labs, Naperville, IL). Vero cells (African green monkey kidney cells)
were plated on uncoated slides. All other cell types were plated on
slides coated with either poly-L-lysine or Cell-Tak (Beckton Dickinson,
Bradford, MA). The cell types included: chick hind limb primary culture
(provided by M. Ruegg, Biocenter of University of Basel), insect SF9
(Spodoptera frugiperda, provided by A. Kempf, Biocenter of University
of Basel), MRC-5 (provided by T. Bachi, University of Zurich), and
Xenopus A6 (provided by F. Verrey, University of Zurich). Treatments
with 10,g/ml brefeldin A (provided by D. Romer and E. Rissi, Sandoz
AG, Basel), 1 ,uM okadaic acid (Boehringer Mannheim, Mannheim,
Germany), or 10 tsg/ml nocodazole (Aldrich, Milwaukee, WI) were
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in normal growth media for the times indicated in the figure legends.
In experiments where the cells were extracted before fixation, the cells
were rinsed with phosphate-buffered saline (PBS) and then extracted
by two consecutive 5-min incubations in 250 ,lA of extraction buffer
(1% Triton X-100, 80 mM piperazine-N,N'-bis(2-ethanesulfonic acid)
[PIPES]pH 6.8, 1 mM MgCl2, 1 mM EDTA, and protease inhibitors)
at 37°C. After any of the above treatments (drug, extraction, or none),
the cells were fixed with 3% paraformaldehyde for 30 min, washed
twice with PBS and twice with PBS containing 20 mM glycine, and
then permeabilized for 20 min with PBS-glycine containing 0.1% sa-
ponin. A 200-,il solution of PBS-saponin containing either none, one,
or two primary antibodies was added for 30 min. The dilutions used
were as follows: anti-giantin (G1/133) at 1:25, anti-galactosyltrans-
ferase (Oscar) at 1:200, anti-tubulin (1A2) at 1:2000, phalloidin at 1
,ug/ml, anti-ERGIC 53 (G1/93) at 1:100. After five washes with PBS-
saponin, 200,ul PBS-saponin containing one or both of the following
antibodies was added: fluorescein isothiocyanate-labeled goat anti-
rabbit (dilution 1:50; Cappel, West Chester, PA), rhodamine isothio-
cyanate-labeled goat anti-rabbit (dilution 1:50; Cappel). After five
final washes with PBS-saponin, the wells were rinsed with PBS, and
a coverslip was attached over mounting media (glycerol containing
0.1 mg/ml phenylenediamine). Analysis was with either a Reichert
Polyvar microscope (Vienna, Austria) or a Bio-Rad MRC-500 confocal
laser scanning microscope system (Richmond, CA).
Metabolic Labeling and Immunoprecipitation
Metabolic labeling with 35S-methionine was as described (Stieger et
al., 1988). Cell lysates were prepared by addition of IP buffer (1%
Triton X-100, 0.2% sodium dodecyl sulfate [SDS], 100 mM NaCl, 5
mM EDTA, 30 mM triethanolamine, pH 8.1, and protease inhibitors)
and passage through a 25-gauge needle. After incubation for 30 min
on ice, the lysate was centrifuged at 100 000 X g for 60 min, and the
resulting supematant (1 ml for each 2-cm filter of Caco-2 or 10-cm
plate of Vero cells) was rotated for 90 min at 4°C with 12,ul G1/133-
coated protein A-Sepharose (Pharmacia, Piscataway, NJ). The Seph-
arose beads were collected and washed four times with 1 ml IP buffer,
rinsed twice to remove excess salt and detergent, boiled in sample
buffer, and analyzed by SDS-polyacrylamide gel electrophoresis
(PAGE) (7% gels) and fluorography. Each 12,l of protein A-Sepharose
was coated by sequential incubations with 2 ul rabbit anti-mouse IgG
(Cappel) and 30 ,AI G1/133.
Immunoblotting
Where indicated, samples were first adjusted to 10% trichloroacetic
acid, incubated on ice for 15 min, and centrifuged for 15 min in a
microcentrifuge. The resulting protein pellet was washed with acetone
and dissolved in sample buffer containing 3 M urea. The proteins
were then subjected to SDS-PAGE on either 7 (Laemmeli, 1970) or
3% (Weber and Osborn, 1969) gels and transferred to nitrocellulose
at 32 V for 2 h in buffer containing 25 mM tris(hydroxy-
methyl)aminomethane (Tris), 192 mM glycine, and 0.1% SDS. The
nitrocellulose was rinsed with 50% methanol to remove SDS and was
stained with Ponceau S (Serva). All subsequent incubations were in
PBS containing 5% nonfat dry milk and 0.05% Tween-20 (Serva).
The nitrocellulose was blocked for 60 min followed by incubation
with G1/133 (1:100) for 60 min, three 5-min washes, incubation with
peroxidase coupled goat anti-mouse IgG (1:1000) (Cappel) for 60 min,
and three final washes. The nitrocellulose was processed using en-
hanced chemiluminescence (Amersham, Arlington Heights, IL). In
cases where the immunoblots were reprobed with additional anti-
bodies, the procedures and antibody dilutions were identical.
Cell Fractionation
Caco-2 cells grown to confluency were rinsed twice with ice-cold
PBS, scraped into PBS, and collected by centrifugation. The pellet
was resuspended and centrifuged in homogenization buffer (250 mM
sucrose, 1 mM EDTA, 10 mM tetraethylammonium, pH 7.4, and pro-
tease inhibitors). The washed pellet was resuspended and homoge-
nized in homogenization buffer (1 ml/10 cm plate) by 20 passages
through a 25-gauge needle. The postnuclear supematant was obtained
by centrifugation of the homogenate at 1000 X g for 5 min. To obtain
the P2 and S2 fractions, the postnuclear supernatant was centrifuged
at 27 000 X g for 10 min. The S2 was then separated into P3 and S3
fractions by centrifugation at 200 000 X g for 30 min. To obtain the
Fl fraction, the postnuclear supematant was adjusted to 50% sucrose
(6-ml volume) and placed in the bottom of a centrifuge tube. Then
45% (4 ml) and 10% (1.5 ml) sucrose steps were carefully overlayed.
The resulting step gradient was centrifuged for 3 h at 30 000 rpm in
a Kontron 41.14 swinging bucket rotor (Kontron, Zurich, Switzerland).
The Fl fraction was collected from the 45%/10% interface with a
pipette. Alternatively, the gradient was collected (1 ml/fraction) from
the bottom.
Triton X-114 Phase Partitioning
Triton X-1 14 (Fluka, Buchs, Switzerland) was prepared as described
(Bordier, 1981). The lysis buffer was 1% Triton X-114, 0.5 M NaCl,
10 mM Tris-Cl (pH 7.4) containing the protease inhibitor cocktail,
and 10 mM bromophenol blue (Serva). The Caco-2 Fl fraction was
solubilized with the lysis buffer (1 ml/200 Ag protein) and centrifuged
for 15 min in a microfuge. The lysate was incubated for 3 min at
37°C and then centrifuged at 37°C for 3 min. The detergent pellet
was saved on ice. The supernatant was extracted two additional times
by addition of Triton X-1 14 to 1% followed by the 37°C incubation
and centrifugation. The combined detergent pellets, the final aqueous
phase supematant, and an untreated aliquot of the original lysate
were all adjusted to equal salt and detergent concentrations and then
precipitated with trichloroacetic acid and were analyzed by immu-
noblotting.
Glycosylation Assay
Immunoprecipitations were scaled up as follows. Caco-2 cell lysates
(4 15-cm plates in 16 ml IP buffer) were incubated with 130 Al of
G1/133 for 60 min on ice, 13,ul rabbit anti-mouse (Cappel) was added
for another 30 min on ice, 130 Al protein A-Sepharose was added,
and the sample was rotated at 4°C for 60 min. The beads were collected
and washed three times by rotation for 5 min in 20 ml IP buffer and
rinsed twice and boiled in 200,l sample buffer. The depleted extract
was then subjected to a second immunoprecipitation using the A1/
118 antibody. Each sample was loaded onto two lanes (100 Ml/lane),
separated by SDS-PAGE, transferred to nitrocellulose, and stained as
described above. The nitrocellulose was then cut in two (leaving iden-
tical samples on each half) and processed for carbohydrate detection
using Glycotrack as described by the distributor (Oxford Glycosystems,
Abingdon, UK). The procedure involved sequential incubations in
periodate, biotin-hydrazide, and blocking buffer as specified. To control
for nonspecific biotinylation, the periodate incubation was omitted
for one-half of the nitrocellulose. The nitrocellulose was then probed
with 1 Ag/ml streptavidin-peroxidase (Pierce, Rockford, IL) and pro-
cessed using enhanced chemiluminescence.
Velocity Sedimentation
Caco-2 cells were extracted by scraping and passing through a 25-
gauge needle in buffer containing 1% Triton X-100, 150 mM NaCl,
10 mM Tris, pH 7.4, 1 mM EDTA, and protease inhibitors. Aliquots
(100 Al) of the extract were layered on 4-ml linear 10-25% glycerol
gradients containing the extraction buffer and centrifuged for 12.5 h
at 40 000 rpm in an SW56 rotor (Beckman, Palo Alto, CA). Fractions
(300 Ml each) were collected from the top with a pipette. The protein
in each fraction was precipitated with trichloroacetic acid and assayed
for giantin by immunoblotting. The migration, in parallel gradients,
of sedimentation markers (bovine thyroglobulin and sweet potato beta-
amylase, Sigma) was determined by protein assay (Pierce). The min-
imum axial ratio of giantin was estimated from the Perrin parameter
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(Cantor and Schimmel, 1980). The Perrin parameter was calculated
using equations and assumed values as previously described (Bloom
et al., 1988), except that the Svedberg equation was solved for the
diffusion coefficient by assuming a minimum native molecular weight
of 400 000 for giantin.
RESULTS
Monoclonal Antibody G1/133 Recognizes an
Epitope Localized to the Golgi Apparatus
A membrane fraction enriched in Golgi markers was
prepared from the human intestinal cell line Caco-2
and used to generate mAbs (Schweizer et al., 1988).
One antibody, G1/133, was of the IgGl subclass and
appeared to recognize an epitope restricted to the Golgi
apparatus. In Figure 1A is the pattern generated by in-
direct immunofluorescence staining of the human fi-
broblast cell line MRC-5 with G1/133, as analyzed by
confocal laser scanning microscopy. The striking jux-
tanuclear staining pattern with a ribbon or worm-like
pattern is typical for Golgi proteins. Indeed, the specific
staining pattern of galactosyltransferase in double im-
munofluorescence experiments was nearly indistin-
guishable from that ofG1/133 (Figure 1B). Background
staining of other structures with the G1/133 antibody
was extremely low. Unfortunately, this was not always
the case for the polyclonal antibody against galacto-
syltransferase. Nevertheless, we noted a consistent mi-
nor difference between the two patterns. Wherever a
loop or ring was clearly outlined, the G1/133 pattern
was restricted to the outermost part of the loop, whereas
the galactosyltransferase staining was restricted to the
inner part of the loop (compare arrows in Figure 1, A
and B). As a control, we compared the patterns, in dou-
ble-stained Vero cells, of two antibodies both against
galactosyltransferase (one monoclonal and one poly-
clonal) and did not observe any difference.
Our attempts to use the G1/133 antibody for im-
munoelectron microscopic experiments have been un-
successful. As an alternative method to confirm that the
G1/133 epitope is specific to the Golgi apparatus, we
have performed immunofluorescent experiments on
cells treated with agents that are known to affect Golgi
structure. Again, the cells were simultaneously stained
with the anti-galactosyltransferase antibody to provide
a Golgi marker.
First, Vero cells were treated for various times with
the fungal metabolite brefeldin A, which causes a re-
distribution of Golgi proteins via membrane tubules to
sites in the cell periphery (Doms et al., 1989; Lippincott-
Schwartz et al., 1989; Sandvig et al., 1991). The results
are shown in Figure 2 for 0 (A and B), 2 (C and D), 10
(E and F), and 30 (G and H) min of treatment. The G1/
133 and galactosyltransferase patterns underwent sim-
ilar changes, and at early time points both epitopes were
localized in the same tubules emanating from the Golgi
region toward the cell periphery. The second compound
used was the microtubule depolymerizing agent nocod-
azole, which causes the fragmentation of the Golgi into
"mini" Golgi stacks (Pavelka and Ellinger, 1983; Ro-
galski and Singer, 1984; Ho et al., 1989). We confirmed
that microtubules were disrupted by using an anti-tu-
bulin antibody. After nocodazole treatment the galac-
tosyltransferase and G1/133 patterns were coincident
Figure 1. Comparison of G1/133 (A) and anti-galactosyltransferase (B) staining patterns in MRC-5 cells by confocal immunofluorescence
microscopy. Note that the stained structures occupying a perinuclear position were nearly identical except where the galactosyltransferase
appeared to be localized inside loops outlined by G1/133 staining (arrows). Bar, 8 ,um.
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and included numerous ring-shaped structures dis-
persed throughout the cytoplasm. Finally, we used the
phosphatase inhibitor okadaic acid, which causes a
vesiculation of the Golgi much like that observed during
mitosis (Lucocq et al., 1991). Okadaic acid treatment
resulted in rounding of the cells and dispersal of both
the galactosyltransferase and G1/133 staining patterns.
Reversal of the drug treatment led to accumulation of
both galactosyltransferase and G1/133 in patches be-
fore final recovery of the Golgi pattern.
In summary, the G1/133 pattern was nearly indis-
tinguishable from that of galactosyltransferase in cells
where the Golgi was left intact (untreated), redistributed
into the cell periphery (brefeldin A), fragmented into
dispersed small stacks (nocodazole), or completely ves-
icularized (okadaic acid). When cells were labeled with
the two antibodies, neither the time course of disruption
nor the intermediates visualized were significantly dif-
ferent. We conclude that the G1/133 monoclonal rec-
ognizes an epitope restricted to the Golgi apparatus.
The Epitope Recognized by G1/133 Is Conserved in
Evolution
Because of the characteristic morphology of the Golgi
apparatus in most cell types, we used an immunoflu-
orescence assay to test the tissue and species distribution
of the Golgi epitope recognized by G1/133. This assay
gave a strong specifically localized signal with a char-
acteristic Golgi pattern; there was virtually no staining
in control incubations with no antibody or with a dif-
ferent monoclonal as primary antibody. The G1/133
antibody labeled the Golgi in cell lines from human
intestine (Caco-2), human lung fibroblast (MRC-5)
(Figure 1A), human liver (HepG2), monkey fibroblast
(Vero) (Figure 2A), rat pheochromocytoma (PC12) (Fig-
ure 3D), rat kidney fibroblast (normal rat kidney), ham-
ster ovary (Chinese hamster ovary [CHO]) (Figure 3C),
hamster kidney (baby hamster kidney [BHK]) (Figure
3B), mouse fibroblast (3T3) (Figure 3A), and an explant
from chick hind limb (Figure 3E). The antibody did not
stain a Xenopus cell line (A6) or an insect cell line (SF9)
(Figure 3F). The widespread crossreactivity indicates that
the epitope is expressed in a variety of tissues and has
been conserved during vertebrate evolution.
The G1/133 Epitope Is Contained in Giantin, a
Novel Golgi Protein of Apparent Molecular Weight
400 kDa
Immunoblotting and immunoprecipitation experiments
were carried out on extracts from either the human
Caco-2 cell line or the monkey Vero cell line using the
G1/133 monoclonal antibody. Additional cell lines have
not yet been examined. Both techniques revealed that
the antibody reacts specifically with a protein present
in both cell types of extremely low mobility on SDS-
PAGE (Figure 4, A and B). The apparent molecular
weight of the protein, 400 kDa, was calculated using
the migration of cross-linked phosphorylase B as a ref-
erence (Figure 8, lane 1). The use of this set of molecular
weight markers required an alternative SDS-PAGE sys-
tem (Weber and Osborn, 1969). To our knowledge very
few proteins, and no Golgi-localized proteins, with a
monomeric molecular weight of 400 kDa have been
characterized. Therefore, we conclude that the G1/133
antibody recognizes a previously unidentified protein
that we have named giantin. There was a variable
amount of specific reactivity found at, or just beyond,
the interface between the stacking and resolving gels
(Figure 4, A and B). It has not been determined whether
or not this material represents nonspecific aggregates of
giantin.
The specificity of the antibody reactions and the fact
that a protein of the same apparent size was recognized
in two different cell types indicated that giantin was
probably the Golgi protein identified in our immuno-
fluorescence experiments. Additional biochemical ex-
periments suggested that giantin is a membrane protein.
Giantin was recovered in a sedimentable form after cell
fractionation by differential centrifugation and was not
present in the cytosol (Figure 4B). To ensure that the
sedimentation properties of giantin were due to mem-
brane association, postnuclear supernatants were sub-
jected to flotation gradient analysis. Giantin was recov-
ered from the 10%/45% sucrose interface (Figure 4C,
fraction 10), confirming its designation as a membrane
protein. Figure 4B demonstrates that giantin was en-
riched in the floated fraction, termed Fl, because all
lanes were loaded with equal amounts of protein and
processed in parallel.
The membranes in the Fl fraction were subjected to
various treatments, including pH 11.5 extraction in car-
bonate buffer, and were collected by centrifugation.
Pellet and supernatant fractions were then assayed for
the presence of giantin by immunoblotting. The extent
of extraction of proteins into the supernatant was mon-
itored by Ponceau S staining of the nitrocellulose filter
used for the immunoblot. After carbonate extraction the
majority of the stainable bands were extracted. In con-
trast, giantin remained with the membrane pellet under
these conditions (Figure 5A, lanes 7 and 8). Eight sep-
arate experiments using vesicles derived from either
Vero or Caco-2 cells yielded the same result. Giantin
was also recovered in the pellet fraction after incubation
in low salt, high salt, or urea-containing buffer (Figure
5A, lanes 1-6). The minor amount of giantin recovered
in the supernatant after urea treatment (Figure 5A, lane
6) was not present in a second experiment in which a
higher urea concentration (7 M) was used. Treatment
with detergent was required to fully extract giantin into
the supernatant (Figure 5A, lanes 9 and 10). These re-
sults suggest that giantin is likely to be an integral com-
ponent of the Golgi membrane.
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Surprisingly, giantin was recovered entirely in the
aqueous phase after samples were subjected to phase
partitioning with Triton X-114 (Figure 5B). However,
some integral membrane proteins have been observed
to partition into the aqueous phase of Triton X-114,
presumably because this partitioning correlates with the
amount of hydrophilic surface that a given protein dis-
plays (Alcarez et al., 1984). As controls in our experi-
ments, the same blots were reprobed with antibodies
against two known integral membrane proteins. One,
the transferrin receptor, was recovered in the detergent
phase as expected, but the other, p63 (Schweizer et al.,
1993a,b), was recovered in the aqueous phase (Figure
5B). Taken together, the extraction and Triton X-114
phase partitioning experiments suggest that giantin is
an integral membrane protein with a large amount of
hydrophilic surface area (see below).
Giantin exhibited a slow turnover rate when cells
were metabolically labeled for 15 min and chased for
up to 18 h (Figure 6A). In these experiments giantin
migrated as a relatively sharp band on SDS-PAGE and
showed no change in mobility during the chase period.
No increase in molecular weight because of glycosyla-
tion was apparent. Because it is uncertain whether a
shift in the mobility of a 400-kDa protein would be
detected, an independent test for glycosylation was also
used. In this experiment giantin was immunoprecipi-
tated and transferred to nitrocellulose where it was vi-
sualized by Ponceau S staining. The nitrocellulose was
then either left untreated or treated with periodate. The
periodate treatment results in oxidation of carbohy-
drates, which can then be labeled with biotin-hydrazide
(Bayer et al., 1990). Periodate-specific biotinylation was
found for several control proteins (the 1 18 antigen [Lin-
stedt and Hauri, unpublished data], antibody heavy
chains, and ovalbumin) but not for giantin (Figure 6B).
Giantin showed a weak and apparently nonspecific la-
beling both with and without periodate treatment.
Taken together, the lack of a mobility shift and the lack
of specific labeling with biotin-hydrazide suggest that
giantin is not significantly glycosylated.
Giantin Has a Cytoplasmic Domain of .350 kDa
We used protease treatment of vesicles isolated from
Caco-2 cells to determine whether the G1/133 epitope
is in a cytoplasmic or lumenal domain of giantin. Ad-
dition of either 50 ,g/ml trypsin or 20 ,g/ml proteinase
K to the Fl fraction (1 mg/ml protein) resulted in com-
plete loss of immunoreactivity on immunoblots (Figure
7A). A control protein also localized to the Golgi com-
plex, the 118 antigen (Linstedt and Hauri, unpublished
data), was protected under these conditions but digested
if detergent was added (Figure 7A). This result suggests
that the G1/133 epitope is protease sensitive and in a
cytoplasmic domain of giantin.
When protease digestion was carried out in the pres-
ence of 25 times higher protein concentration (25 mg/
ml postnuclear supernatant), both trypsin and protein-
ase K generated large fragments of giantin, presumably
the result of incomplete digestion. Interestingly, unlike
intact giantin these protease fragments did not sediment
with membranes (Figure 7B). The vesicles in these ex-
periments were shown to be intact by reprobing the
blot with antibody against the 118 antigen that, as ex-
pected, was completely protected (Figure 7B). The ap-
parent molecular weights of the proteinase K fragment
and the largest trypsin fragment (calculated from their
migration on the Weber and Osborn gel system) were
200 and 350 kDa, respectively (Figure 8, lanes 2 and
3). Because protease digestion releases these fragments
(containing the G1/133 epitope) into a freely soluble
form and because the membrane vesicles were intact,
it can be concluded that giantin has a cytoplasmic do-
main with the minimum size of 350 kDa.
Giantin Is a Highly Elongated Disulfide-bonded
Particle
Giantin was recovered at a significantly retarded posi-
tion after SDS-PAGE under nonreducing conditions
(Figure 8, lane 4), suggesting that it may exist in a di-
sulfide-linked complex. The extracts in these experi-
ments were prepared in the presence of iodoacetamide
to prevent disulfide bond formation after lysis. As a
further control, the trypsin and proteinase K fragments
of giantin were analyzed on the same gels. Because these
fragments are exclusively from a cytoplasmic domain
of giantin, they should not show a change in mobility
under nonreducing conditions unless disulfide bond
formation took place after lysis. As expected, the mi-
gration of the cytoplasmic domain fragments was not
affected by nonreducing conditions (Figure 8). The
finding that giantin has a slower mobility on SDS-PAGE
under nonreducing conditions is further evidence that
giantin spans the Golgi membrane, allowing a lumenal
domain to be modified by disulfide cross-bridging. The
apparent molecular weight of the disulfide-bonded
species was about 600 kDa, but this calculation required
extrapolation beyond the largest marker protein and is
therefore only approximate. Because specific coprecip-
itating proteins were not recovered after immunopre-
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Figure 2. Comparison of G1/133 (A, C, E, and G) and anti-galactosyltransferase (B, D, F, and H) immunofluorescence patterns after brefeldin
A treatment. Vero cells treated with 10 ug/ml brefeldin A for 0 (A and B), 2 (C and D), 10 (E and F), or 30 (G and H) min were double stained
and processed for normal immunofluorescence microscopy. The disruption of the stained structures was simultaneous, and frequently single
tubules were stained by both antibodies. Bar, 8 um.
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Figure 3. G1/133 fluorescence pattern in various cell types. The cell types are 3T3 (A), BHK (B), CHO (C), PC12 (D), chick hind limb explant
(E), and SF9 (F). Bar, 10 ,um.
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Detergent extracts of Caco-2 cells were analyzed on
glycerol velocity gradients to determine the sedimen-
tation properties of giantin. In each of five experiments,
giantin comigrated with beta-amylase, which has a
sedimentation coefficient of 9S (Figure 9). Given that
the giantin particle in the lysate was .400 kDa (note
that these experiments were performed under nonre-
ducing conditions), this rate of sedimentation is sur-
prisingly low, because the molecular weight of beta-
amylase is 200 kDa. Using the sedimentation coefficient
and the minimum molecular weight of the giantin par-
ticle, a minimum estimate of the axial ratio of the particle
can be calculated (see MATERIALS AND METHODS).
For a 400-kDa prolate ellipsoid with a 9S sedimentation
coefficient, the calculated axial ratio is 25 and the di-
mensions are 2.5 nm by 62.5 nm. If the actual native
molecular weight of giantin were greater, this would
imply an even greater axial ratio. Although these are at
best rough estimates, it seems likely that giantin is a
large elongated structure.
Giantin Is Resistant to Extraction by Triton X-100
The large dimensions and predominantly cytoplasmic
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Figure 4. (A) Immunoprecipitation with G1/133. Metabolically la-
beled extracts of Vero cells (lanes 1-3) or Caco-2 cells (lanes 4-6)
were subjected to immunoprecipitation with no primary antibody
(lanes 1 and 4), a nonspecific primary antibody (lanes 2 and 5), or
G1/133 (lanes 3 and 6) followed by SDS-PAGE and fluorography.
A specific reaction resulted in precipitation of a very large protein
designated giantin (Gtn). Note that there was also material at the
stacking/resolving gel interface. Recovery of material at this position
was variable in our experiments. (B) Immunoblotting after differential
centrifugation. Caco-2 cells were separated by differential centrifu-
gation and equal amounts (150 ytg protein) of each fraction were an-
alyzed by immunoblotting with the G1/133 antibody. Shown are the
homogenate (H), the pellets (P), and the supematants (S) from suc-
cessive spins at 1000 X g (P1, S1), 27 000 X g (P2, S2), and 200 000
X g (P3, S3). Giantin was recovered in the P2 fraction and was not
detectable in the S3 (cytosol) fraction. An equal amount of the Fl
fraction (see below) was applied to the same gel; in the photograph
this lane was separated for presentation purposes. (C) Flotation gra-
dient. A Caco-2 postnuclear supematant was adjusted to 50% sucrose
and overlayed with 45% sucrose and 10% sucrose steps. After cen-
trifugation the gradient was fractionated from the bottom, and each
fraction was subjected to an immunoblotting and densitometric scan-
ning to assay for giantin and a protein assay. Fractions 1-6 represent
the material that remained in the 50% sucrose layer, which contained
most of the cellular protein but no detectable giantin. Giantin was
recovered in fraction 10 (designated Fl) that encompassed the 45%/
10% sucrose interface.
cipitation of giantin (Figures 4A and 6A), it is unlikely
that giantin is part of a disulfide-linked hetero-oligomer.
It also seems unlikely that intrachain disulfides could
account for such a large retardation in the mobility of
giantin. For these reasons we speculate that the disul-
fide-linked species is a dimer of two 400-kDa giantin
subunits.
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Figure 5. (A) Extraction of giantin from Caco-2 membrane vesicles.
Aliquots of the Caco-2 Fl fraction (200 ,ug/ml) were incubated on ice
for 30 min in various extraction buffers and then collected by cen-
trifugation (200 000 X g for 30 min). The recovery of giantin (Gtn) in
the pellet fractions (P) and in trichloroacetic acid-precipitated super-
natant fractions (S) was assayed by immunoblotting. The extraction
buffers were 250 mM sucrose buffer (CTRL), 1 M NaCl buffer (SALT),
5 M urea buffer (UREA), 100 mM carbonate, pH 11.5 (CARB), and a
detergent buffer (DET) containing 1% NP40, 0.5% deoxycholate, 0.1%
SDS. (B) Triton X-114 phase partitioning of giantin. The Caco-2 Fl
fraction (400 ,Ag) was solubilized with Triton X-114 lysis buffer and
divided into two equal aliquots. One aliquot was subjected to phase
partitioning, whereas the other aliquot was left untreated. The recovery
of giantin in trichloroacetic acid pellets of the detergent (D) and
aqueous (A) phases was assayed by immunoblotting. The untreated
sample was assayed similarly to determine the total (T) amount of
giantin (Gtn) present in the experiment. The immunoblot was reprobed
with antibodies against transferrin receptor (TfR), p63, and the 118
antigen (1 18a) (Linstedt and Hauri, unpublished data) to determine
the partitioning of other membrane proteins.
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performs a structural role in the Golgi apparatus. To
begin to address this question, we took advantage of
the observation that cytoskeletal and cytoskeleton-as-
sociated proteins are relatively stable to extraction by
1% Triton X-100 (Brown et al., 1976). To test whether
giantin has similar properties, Vero cells were extracted
with 1% Triton X-100 in a microtubule stabilizing buffer
(Navone et al., 1992) for 10 min at 37°C before fixation.
The cells were then processed for immunofluorescence
microscopy using the antibody against giantin as well
as several control antibodies. In these experiments there
was no detectable extraction of giantin (compare Figure
10, A and B). In fact, except for a slight loss in the
resolution of individual Golgi loops, the basic structure
of the Golgi as visualized by staining with the antibody
against giantin was unperturbed. In contrast, three in-
tegral membrane proteins, one localized exclusively to
the Golgi apparatus (galactosyltransferase; Figure 10, C
and D) and two that are found both in the Golgi and
in other compartments (ERGIC-53, Figure 10, E and F,
and mannose-6-phosphate receptor), were completely
extracted. As expected, both the microtubule network
(Figure 10G) and the actin network (Figure 10H) were
left intact under these conditions. The inextractability
of giantin may mean that it is associated with the cy-
toskeleton.
DISCUSSION
We have identified a protein with an apparent subunit
molecular weight of 400 kDa that is restricted to the
Golgi complex. Polypeptides with such a large unit size
are rare. To our knowledge the largest previously known
proteins that are localized exclusively to the Golgi are
MG-160, a 160-kDa sialoglycoprotein (Gonatas et al.,
1989); GIMPC and GIMPt, 130- and 100-kDa glycopro-
teins (Yuan et al., 1987); and the 133-kDa enzyme alpha-
mannosidase II (Moremon and Robbins, 1991). Protease
protection assays indicate that these proteins are pre-
dominantly lumenal with small cytoplasmic domains.
Large proteins with partial Golgi localization include
the 215-kDa cation-independent mannose 6-phosphate
receptor, which recycles between the Golgi and a pre-
lysosomal compartment (Griffiths et al., 1988); two pe-
ripheral membrane proteins of -200 kDa that dissociate
from the Golgi membrane after brefeldin A treatment
(Kooy et al., 1992; Narula et al., 1992); and Sec7p, a
227-kDa peripheral membrane protein required for
protein transit through the yeast Golgi apparatus (Fran-
zusoff et al., 1991).
We believe giantin to be an integral component of
the Golgi membrane, because it was not extracted from
the membrane by high salt, urea, or alkaline carbonate
(Figure 5A). The tight association of giantin with the
Golgi membrane was also apparent in fractionation ex-
periments where intact giantin was recovered exclu-
sively in membrane-containing fractions (Figure 4, B
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Figure 6. (A) Recovery of giantin after various times of chase. Caco-
2 cells were pulse labeled for 15 min with [35S]methionine and sub-
sequently chased for the indicated times. Giantin was recovered by
immunoprecipitation and the immunoprecipitates were analyzed by
SDS-PAGE and fluorography. Note that there was neither a change
in mobility nor an apparent loss of giantin with increasing chase times.
(B) Carbohydrate detection assay. Identical sets of samples were sep-
arated by SDS-PAGE and transferred to nitrocellulose. As indicated,
one set was treated with periodate and the other left untreated. Both
were then incubated with biotin-hydrazide, and the biotinylated pro-
teins were detected with streptavidin-peroxidase. The samples were
5 jig bovine serum albumin (lane 1), 5 ,g ovalbumin (lane 2), im-
munoprecipitated giantin (lane 3), and immunoprecipitated 118 an-
tigen (lane 4). Note that a periodate-specific signal is evident for the
118 antigen (118a), the antibody heavy chains (Ab), and ovalbumin
(Oval) but not for giantin (Gtn) or bovine serum albumin (BSA).
and C). Moreover, giantin remained associated with
Golgi membranes, as judged by coincident staining with
galactosyltransferase, during major perturbations of
Golgi structure with various pharmacological agents
(Figure 2). Under nonreducing conditions giantin had
a decreased mobility, suggesting that the protein con-
tains a disulfide-linked lumenal domain (Figure 8), and
protease experiments indicated that the protein also
contains a significant cytoplasmic domain (Figure 7).
The finding that giantin partitions into the aqueous
phase after Triton X-1 14 extraction does not contradict
the conclusion that giantin is an integral membrane
protein, because the distribution of a protein between
the detergent and aqueous phases reflects the overall
balance between the hydrophobic and hydrophilic
properties of the protein's surface (Alcaraz et al., 1984).
That the majority of the surface area of giantin is hy-
drophilic was indicated by limited protease digestion,
which liberated a number of freely soluble fragments,
including one with an apparent molecular weight of
350 kDa (Figures 7 and 8).
Two findings support the conclusion that this 350-
kDa fragment is part of a contiguous cytoplasmic do-
main of giantin. First, the digestion was carried out un-
der conditions where intracellular membranes, including
Golgi-derived vesicles, were shown to be intact and
sealed (Figure 7B). Second, Golgi vesicles could be im-
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Figure 7. (A) Protease protection of giantin. Membrane vesicles (1
mg/ml Caco Fl fraction) were incubated on ice for 60 min with ad-
ditions of trypsin (50 ug/ml), proteinase K (20 Ag/ml), and Triton X-
100 (1%) where indicated. Each sample was adjusted to equal amounts
of protease inhibitors, protease, and detergent before precipitation
with trichloroacetic acid. Giantin (Gtn) recovery was assayed by im-
munoblotting. To control for vesicle lysis the immunoblot was reprobed
with an antibody that recognizes a lumenally-oriented Golgi antigen
(1 18a). (B) Release of soluble fragments of giantin. Aliquots of Caco-
2 postnuclear supematants (25 mg/ml) were incubated on ice for 30
min with a protease inhibitor cocktail (inh), no addition (4)), proteinase
K (0.01 or 10 ytg/ml), or trypsin (0.05 or 50 Ag/ml) as indicated. The
fractions were separated into membrane pellets (P) and supematants
(S) by centrifugation at 200 000 X g for 30 min, and the recovery of
giantin fragments was assayed by immunoblotting. As in A, the blot




Figure 8. Migration of giantin and proteolytic fragments of giantin
on nonreducing SDS-PAGE. Caco-2 cell lysates (4) were prepared in
a buffer containing iodoacetamide (2% SDS, 10 mM Tris-HCl, pH
7.4, 1 mM EDTA, 5.4 mM iodoacetamide, and the protease inhibitor
cocktail). Reducing (red.; 100 mM dithiothreitol final concentration)
or nonreducing sample buffer (nonred.) was added, and the proteins
were separated as described (Weber and Osbom, 1969) and transferred
to nitrocellulose. The position of giantin was determined by immu-
noblotting. Also analyzed were the high-speed supematants from
proteinase K (PK)- and trypsin (T)-treated postnuclear supernatants
(see legend to Figure 7B).
munoisolated with beads coated with the G1/133
monoclonal antibody (Linstedt and Hauri, unpublished
data). Velocity gradient analysis indicated that giantin
has a highly elongated shape; therefore, it seems likely
that giantin's large cytoplasmic domain projects away
from the Golgi membrane.
The conservation of the G1/133 epitope among avian
and mammalian species indicates that the antibody
binding site itself may be an important domain in the
function of giantin. Because the antibody recognizes this
site after denaturation of the protein with SDS, it is
likely that the antibody binds a contiguous stretch of
amino acids. We will need additional antibodies against
giantin, or gene sequence information, to determine
whether other stretches within the protein are similarly
conserved. Several antibodies have been described that
recognize conserved peripheral components of the Golgi
membrane (Willison et al., 1989; Goud et al., 1990;
Stearns et al., 1990; Kooy et al., 1992), but the degree
of conservation we have found for the G1/133 epitope
is unique among the known integral components of the
Golgi complex. Although the glycosylation of secretory
proteins exists in all cell types with a secretory pathway,
most mAbs against glycosylation enzymes show species
and even tissue specificity in their cross-reactivity.
The conservation of the G1/133 epitope on giantin
allows us to study the distribution of a single Golgi pro-
tein in a variety of tissues and species. From such studies
is it likely that our knowledge of Golgi structure and
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Figure 9. Velocity sedimentation of giantin. After sedimentation
through glycerol gradients, the recovery of giantin in each fraction
was determined by immunoblotting. Fraction numbers start from the
top of the gradient. The peak positions of two reference proteins,
thyroglobulin (19S) and beta-amylase (9S), were determined from
parallel gradients. Giantin was not detectable in the material recovered
as a pellet (P) at the bottom of the gradient. For this experiment Caco-
2 cells were extracted by scraping and passage through a 25-gauge
needle in ice-cold buffer containing 1% Triton X-100, 150 mM NaCl,
10 mM Tris, pH 7.4, 1 mM EDTA, and the protease inhibitor cocktail.
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subcompartmentalization can be extended. Unfortu-
nately, giantin has not yet been localized by immuno-
electron microscopy. Until this is accomplished, the
precise location of giantin within the Golgi will not be
known. However, two observations suggest that the
protein is not uniformly distributed throughout the
Golgi apparatus in Vero cells. First, the immunofluo-
rescence pattern shares a characteristic of markers such
as alpha-mannosidase II and galactosyltransferase,
which are thought to be restricted to subcompartments
of the Golgi. These markers, like giantin, yield a precise
pattern in which the loops and extensions of the Golgi
ribbon are often resolved from one another (Figure 1).
In contrast, if the Golgi complex is uniformly labeled;
for example, with certain lectins or with antibodies
against secretory proteins transiting the Golgi complex,
a significantly more diffuse pattern is usually obtained
(Lewis and Pelham, 1992; Ridgway et al., 1992). Second,
we consistently observed areas where the galactosyl-
transferase and giantin patterns were segregated from
one another, albeit by extremely short distances (Figure
1). There is precedence for resolution of Golgi subcom-
partments using fluorescence microscopy (Antony et al.,
1992; Nilsson et al., 1993). Nevertheless, we feel that
firm conclusions cannot be drawn without an electron
microscopic analysis.
The biochemical features of giantin are sufficiently
distinct from those of known Golgi proteins to warrant
the speculation that giantin has a novel function. As
described in the INTRODUCTION, proteins localized
to the Golgi complex would be expected to fall into at
least three functional categories: those involved in post-
translational modifications such as glycosylation, those
involved in transport and sorting, and those that estab-
lish and regulate the Golgi structure. Although there
are no known members of this latter group, we hy-
pothesize that giantin serves a structural role in the Golgi
as its physical characteristics resemble those that would
be predicted for such proteins.
Thus, the intercistemal filaments or cross-bridges that
are proposed to mediate Golgi stacking (Mollenhauer
and Morre, 1991; Cluett and Brown, 1992) are likely to
be conserved proteins with an exclusive Golgi localiza-
tion, tight membrane binding, and large cytoplasmic
domains. Particularly striking is the similarity of the
size and apparent membrane topology of giantin with
the calcium-release channel (also known as ryanodine
receptor) localized to the sarcoplasmic reticulum of
skeletal muscle and the inositol 1,4,5-trisphosphate re-
ceptor (InsP3 receptor, also known as P400) localized to
subcompartments of the endoplasmic reticulum. The
calcium-release channel is an integral membrane protein
with a molecular mass of 565 223 (z400 kDa on SDS-
PAGE) of which 90% comprises a contiguous cyto-
plasmic domain (Takeshima et al., 1989). This domain
forms a foot structure that links the membranes of the
sarcoplasmic reticulum and the transverse tubule, a
specialization of the muscle cell plasma membrane
(Chadwick et al., 1988; Lai et al., 1988). Indeed, Cluett
and Brown (1992) were struck by the morphological
similarity between the calcium-release channel foot
structure and the intercisternal cross-bridges they vi-
sualized in rat liver Golgi. The InsP3 receptor has se-
quence similarity with the calcium-release channel and
is also a large (313 kDa) integral membrane protein
containing a large contiguous cytoplasmic domain (Fu-
ruichi et al., 1989). In Purkinje cells this receptor is
highly enriched in a subcompartment of the endo-
plasmic reticulum identified as stacked cisternae sepa-
rated by regularly spaced cross-bridges (Satoh et al.,
1990). The identity of the cross-bridges is unknown;
however, their size and shape correspond to that of the
isolated InsP3 receptor (Maeda et al., 1990). It will be
interesting to see whether the InsP3 receptor, the cal-
cium-release channel, and giantin are part of a class of
large multifunctional integral membrane proteins that
contain large cytoplasmic domains capable of forming
intermembrane cross-bridges.
Resistance to extraction with nonionic detergent is a
common feature of the cytoskeleton and its associated
proteins (Brown et al., 1976). Further experiments are
necessary to determine the basis of the inextractability
of giantin. The fact that Triton X-100 extraction had
very little effect on the giantin pattern, whereas other
Golgi membrane proteins were completely extracted
(Figure 10), suggests that giantin may be part of a Golgi
skeleton. The existence of such a structure would have
implications for mechanisms of Golgi organization and
the retention of endogenous Golgi proteins.
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Figure 10. Immunofluorescent staining of Vero cells extracted before fixation. Shown are the fluorescence patterns of giantin in unextracted
(A) and extracted (B) cells, galactosyltransferase in unextracted (C) and extracted (D) cells, ERGIC-53 in unextracted (E) and extracted (F) cells,
tubulin in extracted cells (G), and actin in extracted cells (H). Extraction was performed by treatment at 37°C for 10 min with 1% Triton X-
100 in 80 mM PIPES-KOH pH 6.8, 1 mM EGTA, 1 mM MgCl2, and a protease inhibitor cocktail (see MATERIALS AND METHODS). These
cells were then fixed and processed in parallel with the unextracted cells. The giantin photographs (A and B) were taken with identical exposure
times. There was no apparent extraction of giantin. Bar, 10 Am.
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